6
Oct
2026
Srs Life Sciences Pte. Ltd.
About Srs Life Sciences Pte. Ltd.
Certifications
-
GMP
Categories
Meet us at
-
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026stand 14B26
-
Country/Region:Singapore
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
Contact info
-
-
71 Robinson Road, #14-01, 068895, Singapore, Singapore
Products from Srs Life Sciences Pte. Ltd. (16)
-
Product Canagliflozin Tablets
Meets the RLD EU, US InvoKana, Ready for tech transfer, Dossier readiness Q2 2027 -
Product Lacosamide ER Capsule
RLD : Motpply XR US
Tech Transfer Readiness- Q2 2027 -
Product Cariprazine Capsules
Under development, The RLD used is Vraylar, Tech transfer readiness Q4 2026, Dossier readiness Q3 2027 -
Product Fosfomycin Trometamol granules for oral solution 3g
RLD used is Zambon and product is available for out-licensing in EU countries and Brazil -
Product Ademetionine Tablets
Meets the RLD Heptral and Ready for tech transfer, Dossier readiness Q2 2027 -
Product Deferasirox Sprinkle Oral Granules
Deferasirox Sprinkle granules were developed to improve palatability and patient adherence.
and it is in compliance to EU RLD Jadenu
Dossier Ready for ROW and emerging markets
Dossier Ready for EU- Q2 2027
-
Product Deferoxamine mesylate for injection
The API will be used for the development of generic version of Desferal injection -
Product Ertugliflozin and combination Tablets
Ertugliflozin tablets, marketed under the brand names STEGLATRO, STEGLUJAN, and SEGLUROMET, is still under development. -
Product L-Glutamine oral powder
Rare disease product
Developed in India, a generic version of Endari approved in US
Dossier ready for emerging Markets
Will undergo clinical Trials for sickle cell in Q3 2026 -
Product Spherical Carbon Adsorbent in fine granules
Meets the Japan RLD Kremezin granules, worldwide charcoal tablets are already available. The carbon in granule form is more easy to use
Dossier Readiness Q4 2026 -
Product Suxibuzone and Suxibuzone sachet
Suxibuzone is an analgesic used for joint and muscular pain. It is a prodrug of the non-steroidal anti-inflammatory drug (NSAID) phenylbutazone, -
Product Sevelamer Carbonate powder for oral suspension 0.8g, 2.4g
RLD is Renvela (Genzyme). It is open for outlicensing for EU, Canada, Australia and Emerging countries.
Srs Life Sciences Pte. Ltd. Resources (1)
-
Video SRS Life Sciences Pte Ltd at CPHI Worldwide 2018
Rajah Dubey, Chief Technical Strategist of SRS Life Sciences, speaks with CPHI TV at CPHI Worldwide in Madrid.